|
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China
|
BEIJING and SHANGHAI and BOSTON, Dec. 6, 2021 /PRNewswire/ -- Jacobio Pharma (1167.HK) has received the Investigational New Drug (the "IND") approval of the combination therap...
Full "IntellAsia: Resources" article
|
|